Thema: US07725L1026
ONC, US07725L1026
coin-1549045_1920.jpg - Foto: THN
BeOne Medicines stock: Morgan Stanley maintains USD 425 target
BeOne Medicines stock was quoted at EUR 331.00 in late trading on October 29. Morgan Stanley maintains its positive view of the oncology company.
ad-hoc-news.de, 30.10.26 02:08 Uhr
ONC, US07725L1026
Morgan Stanley raises target for BeOne Medicines stock to ...
ESMO 2026 runs October 23-27 in Madrid with 12 BeOne abstracts. BeOne Medicines stock costs EUR 339.00 on October 20, 2026 at 7:32 p.m. CEST.
ad-hoc-news.de, 20.10.26 19:37 Uhr
ONC, US07725L1026
Morgan Stanley lifts target for BeOne Medicines stock to ...
June-quarter revenue was USD 1.71 billion. BeOne Medicines stock cost USD 369.06 on October 16, 2026, down 1.34 percent versus Nasdaq's prior close.
ad-hoc-news.de, 17.10.26 20:02 Uhr
ONC, US07725L1026
RBC raises target for BeOne Medicines stock to USD 459.00 ...
Revenue reached USD 1.71 billion in the second quarter, up 30.00 percent. BeOne Medicines stock costs EUR 311.00 after EUR 325.00 on October 8, 2026.
ad-hoc-news.de, 08.10.26 21:11 Uhr
ONC, US07725L1026
JPMorgan raises target for BeOne Medicines stock to USD ...
JPMorgan moved its target from USD 425.00 to USD 445.00 on October 1, 2026. BeOne Medicines stock costs EUR 324.00 after EUR 316.00, plus 2.53 percent.
ad-hoc-news.de, 05.10.26 12:41 Uhr
BGNE, US07725L1026
BeiGene stock gains 2.16 percent as biotech shares rise
BeiGene stock gained 2.16 percent on September 22, 2026, in Hong Kong trading. The move came as several biotech shares also advanced.
ad-hoc-news.de, 23.09.26 02:37 Uhr
BGNE, US07725L1026
BeiGene stock holds steady as investors digest recent quarterly ...
BeiGene stock reflects recent quarterly losses from the latest reported results as of August 2026 while investors weigh its oncology pipeline. The shares trade on Nasdaq with ...
ad-hoc-news.de, 20.09.26 13:03 Uhr
